Research programme: G-protein coupled receptors targeting therapeutics - Nxera Pharma/InveniaAI
Latest Information Update: 02 Apr 2024
At a glance
- Originator InveniAI; Sosei Heptares
- Developer InveniAI; Nxera Pharma
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Immunological disorders